Cogent Biosciences (COGT) News Today $7.62 +0.21 (+2.77%) Closing price 07/3/2025 03:32 PM EasternExtended Trading$7.60 -0.02 (-0.20%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock COGT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Wedbush Increases Earnings Estimates for Cogent BiosciencesJuly 3 at 7:50 AM | marketbeat.comQ2 Earnings Estimate for COGT Issued By Lifesci CapitalJuly 3 at 2:38 AM | americanbankingnews.comWhat is Lifesci Capital's Estimate for COGT Q2 Earnings?July 1, 2025 | marketbeat.comCogent Biosciences' (COGT) "Neutral" Rating Reaffirmed at WedbushJune 30, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Given "Hold" Rating at Needham & Company LLCJune 17, 2025 | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Cabaletta Bio (CABA), Cogent Biosciences (COGT) and Biogen (BIIB)June 14, 2025 | theglobeandmail.comBank of America Corp DE Reduces Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT)June 14, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Receives Average Recommendation of "Moderate Buy" from AnalystsJune 13, 2025 | marketbeat.comCogent Biosciences Secures up to $400 Million in Non-Dilutive FinancingJune 11, 2025 | globenewswire.comTwo Sigma Advisers LP Has $148,000 Stake in Cogent Biosciences, Inc. (NASDAQ:COGT)June 8, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Wellington Management Group LLPJune 6, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Trading 6.5% Higher - Should You Buy?June 5, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Shares Gap Up - Here's WhyJune 3, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Stock Price Down 5.7% - Here's What HappenedMay 31, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Stock Price Up 11.6% After Analyst UpgradeMay 30, 2025 | marketbeat.comJPMorgan Chase & Co. Issues Positive Forecast for Cogent Biosciences (NASDAQ:COGT) Stock PriceMay 30, 2025 | marketbeat.comDeutsche Bank AG Reduces Position in Cogent Biosciences, Inc. (NASDAQ:COGT)May 30, 2025 | marketbeat.comCogent Biosciences Announces Participation in the Jefferies Global Healthcare ConferenceMay 29, 2025 | globenewswire.comBNP Paribas Financial Markets Buys Shares of 66,784 Cogent Biosciences, Inc. (NASDAQ:COGT)May 26, 2025 | marketbeat.comResearch Analysts Set Expectations for COGT Q2 EarningsMay 24, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Sells 117,240 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)May 22, 2025 | marketbeat.comNorthern Trust Corp Grows Position in Cogent Biosciences, Inc. (NASDAQ:COGT)May 22, 2025 | marketbeat.comTema Etfs LLC Takes Position in Cogent Biosciences, Inc. (NASDAQ:COGT)May 21, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Recommendation of "Moderate Buy" by AnalystsMay 21, 2025 | marketbeat.comPoint72 Asset Management L.P. Reduces Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT)May 18, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Holdings Raised by Paradigm Biocapital Advisors LPMay 16, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) is Octagon Capital Advisors LP's 8th Largest PositionMay 15, 2025 | marketbeat.comQ2 EPS Estimate for Cogent Biosciences Lifted by AnalystMay 13, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Deerfield Management Company L.P. Series CMay 10, 2025 | marketbeat.comAlgert Global LLC Has $2.69 Million Stake in Cogent Biosciences, Inc. (NASDAQ:COGT)May 10, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Issues Earnings ResultsMay 8, 2025 | marketbeat.comCogent Biosciences Reports First Quarter 2025 Financial ResultsMay 6, 2025 | globenewswire.comCogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Invesco Ltd.May 6, 2025 | marketbeat.comLeerink Partnrs Has Strong Forecast for COGT FY2026 EarningsMay 3, 2025 | marketbeat.comCogent Biosciences (COGT) to Release Quarterly Earnings on TuesdayMay 1, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Trading 3.8% Higher - Here's What HappenedApril 30, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Shares Bought by Nantahala Capital Management LLCApril 30, 2025 | marketbeat.comRenaissance Technologies LLC Makes New Investment in Cogent Biosciences, Inc. (NASDAQ:COGT)April 28, 2025 | marketbeat.comCogent Biosciences, Inc. (NASDAQ:COGT) Shares Acquired by Adage Capital Partners GP L.L.C.April 27, 2025 | marketbeat.comCogent Biosciences appoints Ray Frost as SVP, Market AccessApril 26, 2025 | markets.businessinsider.comCogent to present preclinical data from pipeline programs at AACR meetingApril 26, 2025 | markets.businessinsider.comCogent Biosciences, Inc. (NASDAQ:COGT) Receives Consensus Rating of "Moderate Buy" from BrokeragesApril 26, 2025 | marketbeat.comCogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New LeadersApril 25, 2025 | globenewswire.comSilverarc Capital Management LLC Has $7.19 Million Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT)April 24, 2025 | marketbeat.comDiadema Partners LP Acquires New Position in Cogent Biosciences, Inc. (NASDAQ:COGT)April 24, 2025 | marketbeat.comXTX Topco Ltd Takes $457,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT)April 23, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Trading Down 7.6% - Should You Sell?April 18, 2025 | marketbeat.comWalleye Capital LLC Boosts Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT)April 18, 2025 | marketbeat.comCogent Biosciences (NASDAQ:COGT) Shares Up 6.1% - Time to Buy?April 17, 2025 | marketbeat.comAlliancebernstein L.P. Buys 382,882 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT)April 16, 2025 | marketbeat.com Get Cogent Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter. Email Address COGT Media Mentions By Week COGT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COGT News Sentiment▼0.900.58▲Average Medical News Sentiment COGT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COGT Articles This Week▼114▲COGT Articles Average Week Get Cogent Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for COGT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MoonLake Immunotherapeutics News Metsera News Viking Therapeutics News Kymera Therapeutics News MorphoSys News Crinetics Pharmaceuticals News Alvotech News Immunovant News Catalyst Pharmaceuticals News HUTCHMED News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:COGT) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogent Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cogent Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free COGT Stock Alerts